Menu

Partnership Valuation in Pharma

By Visited 456 times , 1 Visits today

Start Date: 2014-12-01
End Date: 2014-12-02
Time: 9:00 am to 5:00 pm

Phone: +49 (0)30 20913 274

Location: Movenpick Hotel Berlin, Schoneberger Strasse 3, Berlin, 10963, Germany

Website

Get Direction View Large Map

Description

• Deepen your understanding of the complex aspects in valuation of products, companies and technology platforms
• Listen to best practice examples from pharmaceutical and biotech companies, their strategies and tools to master challenges like pricing and reimbursement
• Hear about the different valuation models of early stage products versus late stage products

Companies and institutes invited to speak:
• AstraZeneca AB
• Merck and Co.
• Bayer Pharma AG
• Novartis AG
• Hoffmann-La Roche Ltd.
• Medivir AB
• Avance
• Gilead Sciences, Inc.
• Boehringer Ingelheim GmbH
• Sanofi S.A.
• Bayer Schering Pharma AG
• Polyphor Ltd.
• Grünenthal GmbH
• Novo Nordisk A/S
• Merck Serono
• Amgen, Inc.
• Pfizer, Inc.
• Astellas Pharma, Inc.
• MorphoSys AG
• UCB Pharma Ltd.

Price:
Bronze Package 2 day conference: €2,549,- + VAT

Speakers: Dr. Kay Brickmann – Business Development Director Scientific Partnering and Alliances – AstraZeneca AB – Sweden, Morten Faester – Director Business Development – Medivir AB – Sweden, Ralph Villiger – Managing Director – Avance – Switzerland

Registration Information

Register Now

Organizers

Organized by :  IQPC Germany

About the Organizers :